Author

Jill A. Poole

University of Nebraska Medical CenterORCID 0000-0002-6236-2563Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Aditya SundariD· 1 shared Ashley R. RavnholdtiD· 1 shared Atefehsadat MonirvaghefiiD· 1 shared Braeden R. Pinkerton· 1 shared C. J. Woslager· 1 shared Chinmay M. JogdeoiD· 1 shared David OupickýiD· 1 shared James E. TalmadgeiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Aditya SundarORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhalable Perfluorocarbon RNA Nanocapsules Bypass Immune Clearance While Targeting Lung Epithelial and Lung Tumor Cells

Kasturi Siddhanta, Atefehsadat Monirvaghefi, Aditya Sundar, Braeden R. Pinkerton, Neha Kumari, Ling Ding, C. J. Woslager, Marjina Akter Kalpana, Chinmay M. Jogdeo, Ashley R. Ravnholdt, Jill A. Poole, Joshua L. Santarpia, James E. Talmadge, David Oupický

This paper develops inhalable perfluorocarbon RNA nanocapsules that bypass immune clearance and target lung cells, showing efficient delivery and therapeutic effects in a lung metastasis model.

bioRxiv · Jun 5, 2025 · PreprintBioengineering